These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1808854)

  • 21. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report.
    Teo SK
    Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tuberculosis treatment today].
    Nowak D; Radenbach D; Kirsten D; Magnussen H
    Z Gesamte Inn Med; 1991 Aug; 46(10-11):404-9. PubMed ID: 1926948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relapse rate of pulmonary tuberculosis within two years following completion of twice weekly intermittent chemotherapy].
    Wada M; Okumura M; Hoshino H; Mitarai S; Ohmori M; Uchimura K; Yoshiyama T; Ogata H
    Kekkaku; 2008 Apr; 83(4):353-8. PubMed ID: 18516898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fully supervised ambulatory short-course chemotherapy with an intermittent regimen for newly diagnosed smear-positive pulmonary tuberculosis].
    Xu RX
    Zhonghua Jie He He Hu Xi Za Zhi; 1987 Oct; 10(5):261-3, 307. PubMed ID: 3131029
    [No Abstract]   [Full Text] [Related]  

  • 26. [Twice-weekly intermittent chemotherapy during the maintenance phase of the short-course treatment for new patients with pulmonary tuberculosis].
    Wada M; Mizoguchi K; Okumura M; Mitarai S; Hoshino H; Ohmori M; Uchimura K; Yoshiyama T; Ogata H
    Kekkaku; 2006 May; 81(5):363-9. PubMed ID: 16768170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The strategy of tuberculosis control in East Germany after 1982].
    Herrmann H
    Z Erkr Atmungsorgane; 1983; 161(1):107-16. PubMed ID: 6636865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Six-month treatment of pulmonary tuberculosis in children. Review of 11 cases].
    Sóle Mir E; Gussiñé Canadell M; Castillo Salinas F; Pérez LaCasta P; Montané Pasamontes C; Bosch Castañé J; Carrascosa Lezcano A
    An Esp Pediatr; 1990 Apr; 32(4):303-6. PubMed ID: 2368992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-tuberculosis chemotherapy].
    Wada M
    Kekkaku; 2007 Oct; 82(10):771-81. PubMed ID: 18018601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short course chemotherapy for pulmonary tuberculosis in routine service in Kenya.
    Babu Swai O; Aluoch JA; Githui W; Darbyshire JH
    East Afr Med J; 1990 Nov; 67(11):748-55. PubMed ID: 2076674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Have the incidence and resistance of tuberculosis increased? Epidemiologic follow-up based on diseases confirmed by culture].
    Schneider C; Lasch C; Brade V
    Pneumologie; 1994 Nov; 48(11):803-8. PubMed ID: 7824502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Resistant lung tuberculosis in Berlin 1987-1993].
    Schaberg T; Gloger G; Reichert B; Mauch H; Lode H
    Pneumologie; 1996 Jan; 50(1):21-7. PubMed ID: 8774931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Shortening of hospitalization period for patients with pulmonary tuberculosis].
    Suzuki A; Tojima H; Hamaoka T; Hujita A; Yamamoto H
    Kekkaku; 1995 Jan; 70(1):17-23. PubMed ID: 7884986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Shortening of therapy duration in patients with pulmonary tuberculosis from 9 to 6 months only justifiable on the basis of published data].
    van Loenhout-Rooyackers JH; Veen J; Verbeek AL
    Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2181-7. PubMed ID: 8984355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic trial of a combination of isoniazid, rifampicin and pyrazinamide in the first 2 months of treatment of pulmonary tuberculosis].
    Bellabas M; Khaled S; Khaled NA; Boulahbal F; Chaulet P
    Rev Mal Respir; 1989; 6(1):59-64. PubMed ID: 2648511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Controlled clinical trial on efficacy of 5-month regimens and whole course intermittent 6-month regimens in treating bacillary pulmonary tuberculosis].
    Chu N; Yan B; Zhu L
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):388-91. PubMed ID: 11326873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The trend of pulmonary tuberculosis in patients seen at DOTS clinics in the Federal Capital Territory, Abuja, Nigeria.
    Bassey EB; Momoh MA; Imadiyi SO; Udofia EB; Miri FS; Anukam KC; Epoke J; Benka-Coker MO; Aluyi HS
    Public Health; 2005 May; 119(5):405-8. PubMed ID: 15780329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.